Paysign (NASDAQ:PAYS) EVP Joan Herman Sells 38,900 Shares

Paysign, Inc. (NASDAQ:PAYS) EVP Joan Herman sold 38,900 shares of the company’s stock in a transaction that occurred on Wednesday, September 16th. The stock was sold at an average price of $11.74, for a total value of $456,686.00. Following the completion of the sale, the executive vice president owned 609,421 shares in the company, valued at approximately $7,154,602.54. This represents a 6.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Paysign Stock Up 5.1%

Shares of NASDAQ:PAYS traded up $0.60 during trading on Thursday, hitting $12.42. 899,844 shares of the stock traded hands, compared to its average volume of 745,622. The company has a fifty day moving average price of $11.46 and a two-hundred day moving average price of $8.01. Paysign, Inc. has a 52-week low of $3.08 and a 52-week high of $14.43. The company has a market cap of $701.23 million, a price-to-earnings ratio of 47.77 and a beta of 0.80.

Paysign (NASDAQ:PAYS) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.06 by $0.05. Paysign had a net margin of 15.67% and a return on equity of 30.13%. The company had revenue of $28.25 million for the quarter, compared to analyst estimates of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. On average, equities research analysts predict that Paysign, Inc. will post 0.58 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on PAYS. Weiss Ratings raised Paysign from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, July 29th. Barrington Research set a $15.00 target price on Paysign in a research note on Tuesday, August 11th. Wall Street Zen lowered Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Lake Street Capital boosted their price target on shares of Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, DA Davidson upped their price objective on shares of Paysign from $9.00 to $12.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $14.00.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in PAYS. Legal & General Group Plc acquired a new stake in Paysign during the 2nd quarter worth $35,000. Caitong International Asset Management Co. Ltd raised its position in shares of Paysign by 381.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 9,876 shares of the company’s stock valued at $51,000 after buying an additional 7,825 shares during the last quarter. EFG International AG purchased a new position in shares of Paysign in the second quarter worth about $68,000. Quantbot Technologies LP purchased a new stake in Paysign during the 2nd quarter valued at about $97,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in Paysign in the 2nd quarter valued at about $100,000. 25.89% of the stock is owned by institutional investors and hedge funds.

About Paysign

Paysign, Inc is a financial technology company that provides payment and financial services primarily to the healthcare and pharmaceutical industries. Its platform supports prepaid card programs, digital payments and other disbursement solutions designed to help organizations distribute funds to individuals efficiently and securely.

The company’s services include patient assistance programs that help eligible patients receive financial support for prescription medications and other healthcare costs.